In view of World Malaria Day (WMD), April 25, scientists across the globe have recorded major breakthrough in a bid to eradicate and eliminate the female anopheles mosquito-borne disease. There is a revelation for the first time solving a long standing mystery, a protein displayed on the surface of malaria parasites called “TRAP” is a high-priority vaccine target but how it interacts with human host cells has remained a puzzle.
Scientists from the Wellcome Sanger Institute have however discovered a receptor protein on the surface of human cells that the TRAP protein interacts with as it navigates through the body. The results, published April 9 in journal PNAS could help improve the development of an effective malaria vaccine.
A consultant pharmacist and past President of Pharmaceutical Society of Nigeria (PSN), Olumide Akintayo said “As we celebrate yet another World Malaria Day, the National Council on Health must consider and approve a preventive control of malaria through the use of safe chemicals to treat the environment”.